Overview

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
This is a research study comparing the safety and efficacy of two active study medications
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Olanzapine
Ziprasidone